Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001171843-15-005108
Filing Date
2015-09-10
Accepted
2015-09-10 09:30:54
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A gff20fa_090915.htm 20-F/A 45254
2 EXHIBIT 4.10 exh_410.htm EX-4.10 22383
3 EXHIBIT 4.11 exh_411.htm EX-4.11 123132
4 EXHIBIT 4.16 exh_416.htm EX-4.16 156964
5 EXHIBIT 4.17 exh_417.htm EX-4.17 7005
6 EXHIBIT 4.18 exh_418.htm EX-4.18 12419
7 EXHIBIT 4.19 exh_419.htm EX-4.19 42229
8 EXHIBIT 12.1 exh_121.htm EX-12.1 9909
9 EXHIBIT 12.2 exh_122.htm EX-12.2 9986
10 GRAPHIC corealis_logo.jpg GRAPHIC 23298
11 GRAPHIC exh411_1.jpg GRAPHIC 113177
12 GRAPHIC asher_sig.jpg GRAPHIC 8171
  Complete submission text file 0001171843-15-005108.txt   624311
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 20-F/A | Act: 34 | File No.: 001-35773 | Film No.: 151100191
SIC: 2834 Pharmaceutical Preparations